[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

Iran says parliament is preparing bill to leave nuclear non-proliferation treaty

Asia Moves Forward to Ditch Dollar: 50% Crash by 2030 Expected?

An Israeli missile interceptor has malfunctioned and crashed in Tel Aviv, according to initial reports.

SIXTY-PERCENT (60%) of ALL Israeli Fuel Supply - OFFLINE

Tucker and Steve Bannon React to New Developments in Iran-Israel Conflict

Russian and Chinese Military Cargo Planes Shuttling weapons, Missiles, Supplies into Iran

Mossad's reach inside Iran exposed as Tehran arrests 28 alleged agents

Israel and US exhausting supplies of ballistic missile interceptors, source says

China's Covert Cargo Flight to Iran Sparks Global Crisis:

FBI Drops EVIDENCE 2020 Election WAS STOLEN By Democrats For Biden, Chinese Plot UNCOVERED

Mohammad Marandi LEAKS: Trump's Secret Nuclear Talks with Israel!

Hanegbi: Iran has far more missiles than estimated; in the thousands

Gutfeld: Kat’s back!

White House Seeks Meeting With Iran's Foreign Minister As Iran Eases Punishing Strikes: Axios

Iran claims they have disabled Israel Iron dome, caused them to attack each other

Prof. Marandi Drops BOMBSHELL: “Tel Aviv Will Burn… Leave While You Can!”

The Prisoner's Dilemma Of AI

"Everyone Should Immediately Evacuate Tehran!", Trump Warns

Ben Hodges: Russia is a Terrible Ally | Jake Broe Podcast (E034)

Burkina Faso's DRONE STRIKE that SHOCKed the WORLD

Speed of Russian missiles in Feet per second

Laura Ingraham was stunned by one awful problem that has Democrats reeling

AOC Fans the Flames of Division in INS*NE Response to Dangerous Protests

Trump Orders ICE to Democrat Sanctuary Cities

How Iran Turned Israels Iron Dome Against Itself Using Clever Jamming

ICE Raid At Omaha Food Plant Results In Dozens Of Arrests, New Applicants For Open Jobs

If We Send Them All Back... WHO WILL PICK THE CROPS?!

What is Palantir and what exactly does it do. You need to know this.

Nearly 1 MILLION illegals have already self deported under Trump!

Trump pretending to resist Israel attack on Iran; constrained because open support would push Saudi into China camp


National News
See other National News Articles

Title: Celgene charges $1,000 for cancer drug that costs 25 cents to make
Source: [None]
URL Source: https://citizenwatchreport.com/celg ... g-that-costs-25-cents-to-make/
Published: May 12, 2025
Author: Horse
Post Date: 2025-05-12 09:13:21 by Horse
Keywords: None
Views: 41

Celgene’s cancer drug pricing has sparked outrage, with patients paying $1,000 per pill for a medication that costs just 25 cents to produce. The drug in question, Revlimid, is a derivative of Thalidomide, a compound infamous for causing severe birth defects in the 1950s and 1960s. Despite its dark history, Thalidomide was repurposed as a treatment for multiple myeloma, a deadly blood cancer. While Revlimid has extended thousands of lives, its staggering price tag has placed it out of reach for many patients.

The numbers tell a troubling story. Revlimid has generated over $100 billion in total sales, making it one of the most profitable drugs in history. Yet the cost to manufacture each pill remains less than a dollar. Patients who rely on the drug often face financial ruin, forced into debt or left with no choice but to stop treatment. This is not about innovation, it’s about profit. Celgene, now owned by Bristol Myers Squibb, has aggressively defended its pricing, arguing that research and development costs justify the high price. However, critics point out that the company has spent far more on marketing and executive compensation than on actual drug development.

The tactics used to maintain Revlimid’s monopoly are equally disturbing. Celgene has repeatedly blocked generic competition, filing over 50 patents to extend its exclusivity. The company has also been accused of paying off potential competitors to delay cheaper alternatives from entering the market. Patients and advocacy groups have called for government intervention, but regulatory action has been slow.

The impact of these pricing schemes extends beyond individual patients. Insurance premiums continue to rise, driven in part by the exorbitant cost of drugs like Revlimid. Taxpayer-funded programs such as Medicare and Medicaid bear the burden, funneling billions into pharmaceutical giants while patients struggle to afford life-saving treatments.

SOURCES:

https://lite.cnn.com/2025/05/10/health/revlimid-price-of-remission- propublica

https://www.yahoo.com/news/price-remission-160051536.html

https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs- fda-multiple-myeloma

Post Comment   Private Reply   Ignore Thread  



[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]